• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项评估幽门螺杆菌感染筛查对预防消化性溃疡和胃癌作用的模拟研究。

A simulation to evaluate screening for Helicobacter pylori infection in the prevention of peptic ulcers and gastric cancers.

作者信息

Davies Ruth, Crabbe David, Roderick Paul, Goddard Jonathan R, Raftery James, Patel Praful

机构信息

School of Management, University of Southampton, UK.

出版信息

Health Care Manag Sci. 2002 Nov;5(4):249-58. doi: 10.1023/a:1020326005465.

DOI:10.1023/a:1020326005465
PMID:12437272
Abstract

A discrete event simulation model has evaluated a screening programme for Helicobacter pylori infection (H. pylori) in which individuals under the age of 50 years would be screened once. Eradication of H. pylori would reduce the peptic ulcer risk immediately and the gastric cancer risk after a fixed delay. The data were derived from published databases and peer reviewed papers. The simulation model, using variance reduction techniques, predicted that a screening programme would reduce morbidity and deaths but could cost around 19 million pounds for England and Wales in the first year of screening. A factorial design analysis showed the sensitivity of key variables. An increase in the opportunistic testing was found significantly to reduce the impact of screening.

摘要

一个离散事件模拟模型对幽门螺杆菌感染(H. pylori)的筛查项目进行了评估,该项目对50岁以下的个体进行一次性筛查。根除幽门螺杆菌可立即降低消化性溃疡风险,并在经过一段固定延迟后降低胃癌风险。数据来源于已发表的数据库和同行评审论文。该模拟模型采用方差缩减技术预测,筛查项目将降低发病率和死亡率,但在筛查的第一年,英格兰和威尔士的成本可能约为1900万英镑。析因设计分析显示了关键变量的敏感性。研究发现,机会性检测的增加可显著降低筛查的影响。

相似文献

1
A simulation to evaluate screening for Helicobacter pylori infection in the prevention of peptic ulcers and gastric cancers.一项评估幽门螺杆菌感染筛查对预防消化性溃疡和胃癌作用的模拟研究。
Health Care Manag Sci. 2002 Nov;5(4):249-58. doi: 10.1023/a:1020326005465.
2
Cost-effectiveness of population screening for Helicobacter pylori in preventing gastric cancer and peptic ulcer disease, using simulation.利用模拟方法评估幽门螺杆菌群体筛查在预防胃癌和消化性溃疡疾病方面的成本效益
J Med Screen. 2003;10(3):148-56. doi: 10.1177/096914130301000310.
3
The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model.幽门螺杆菌筛查对降低胃癌和消化性溃疡疾病死亡率及发病率的成本效益:离散事件模拟模型
Health Technol Assess. 2003;7(6):1-86. doi: 10.3310/hta7060.
4
The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial.人群幽门螺杆菌筛查与治疗的成本效益:一项使用随机对照试验经济数据的马尔可夫模型
Aliment Pharmacol Ther. 2002 Mar;16(3):559-68. doi: 10.1046/j.1365-2036.2002.01204.x.
5
Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases.基线胃黏膜萎缩是消化性溃疡疾病患者幽门螺杆菌根除治疗后发生胃癌的一个相关危险因素。
J Gastroenterol. 2007 Jan;42 Suppl 17:21-7. doi: 10.1007/s00535-006-1924-9.
6
Cost-effectiveness analysis of screen-and-treat strategy in asymptomatic Chinese for preventing Helicobacter pylori-associated diseases.无症状中国人筛查和治疗策略预防幽门螺杆菌相关疾病的成本效果分析。
Helicobacter. 2019 Apr;24(2):e12563. doi: 10.1111/hel.12563. Epub 2019 Jan 22.
7
The cost effectiveness of Helicobacter pylori population screening-economic evaluation alongside a randomised controlled trial with 13-year follow-up.幽门螺杆菌人群筛查的成本效益:一项随机对照试验的经济学评价,随访时间为 13 年。
Aliment Pharmacol Ther. 2019 Apr;49(8):1013-1025. doi: 10.1111/apt.15193. Epub 2019 Mar 10.
8
Helicobacter pylori public health implications.幽门螺杆菌对公共卫生的影响。
Helicobacter. 2004;9 Suppl 1:67-72. doi: 10.1111/j.1083-4389.2004.00250.x.
9
Should we screen for Helicobacter pylori to prevent gastric cancer?我们应该筛查幽门螺杆菌以预防胃癌吗?
Dig Dis. 2007;25(3):218-21. doi: 10.1159/000103888.
10
Using stool antigen to screen for Helicobacter pylori in immigrants and refugees from high prevalence countries is relatively cost effective in reducing the burden of gastric cancer and peptic ulceration.对于来自幽门螺杆菌高流行国家的移民和难民,使用粪便抗原检测来筛查幽门螺杆菌,在减轻胃癌和消化性溃疡负担方面具有相对成本效益。
PLoS One. 2014 Sep 30;9(9):e108610. doi: 10.1371/journal.pone.0108610. eCollection 2014.

引用本文的文献

1
Current Status of Gastric Cancer Screening and Future Perspectives.胃癌筛查的现状与未来展望
DEN Open. 2025 May 26;6(1):e70148. doi: 10.1002/deo2.70148. eCollection 2026 Apr.
2
Evolving Concepts in Helicobacter pylori Management.幽门螺杆菌管理中不断发展的概念。
Gastroenterology. 2024 Feb;166(2):267-283. doi: 10.1053/j.gastro.2023.09.047. Epub 2023 Oct 6.
3
Simulation Models in Gastric Cancer Screening: A Systematic Review.胃癌筛查中的模拟模型:一项系统综述

本文引用的文献

1
The prevalence of dyspepsia and use of antisecretory medication in North Glasgow: role of Helicobacter pylori vs. lifestyle factors.北格拉斯哥消化不良的患病率及抗分泌药物的使用:幽门螺杆菌与生活方式因素的作用
Aliment Pharmacol Ther. 1999 Nov;13(11):1505-9. doi: 10.1046/j.1365-2036.1999.00632.x.
2
General population screening for infection with Helicobacter pylori: a realistic option?
J Med Screen. 1998;5(3):162-6. doi: 10.1136/jms.5.3.162.
3
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.使用奥美拉唑与两种抗菌药物联合的一周三联疗法根除幽门螺杆菌:MACH I研究
Asian Pac J Cancer Prev. 2018 Dec 25;19(12):3321-3334. doi: 10.31557/APJCP.2018.19.12.3321.
4
Cost-effectiveness of Helicobacter pylori screening followed by eradication treatment for employees in Japan.日本员工中幽门螺杆菌筛查及根除治疗的成本效益分析。
Epidemiol Infect. 2018 Oct;146(14):1834-1840. doi: 10.1017/S095026881800208X. Epub 2018 Jul 30.
5
Cost-effectiveness analysis of universal noninvasive testing for post-treatment confirmation of Helicobacter pylori eradication and the impact of patient adherence.幽门螺杆菌根除治疗后采用普遍无创检测进行确认的成本效益分析及患者依从性的影响
Patient Prefer Adherence. 2016 Jun 8;10:1025-35. doi: 10.2147/PPA.S102760. eCollection 2016.
6
Impact of patient adherence on the cost-effectiveness of noninvasive tests for the initial diagnosis of Helicobacter pylori infection in the United States.患者依从性对美国幽门螺杆菌感染初始诊断非侵入性检测成本效益的影响。
Patient Prefer Adherence. 2016 Jan 21;10:45-55. doi: 10.2147/PPA.S93320. eCollection 2016.
7
Applying reinforcement learning techniques to detect hepatocellular carcinoma under limited screening capacity.在有限筛查能力下应用强化学习技术检测肝细胞癌。
Health Care Manag Sci. 2015 Sep;18(3):363-75. doi: 10.1007/s10729-014-9304-0. Epub 2014 Oct 12.
8
Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention.筛查和治疗幽门螺杆菌预防胃癌的成本效益。
Best Pract Res Clin Gastroenterol. 2013 Dec;27(6):933-47. doi: 10.1016/j.bpg.2013.09.005. Epub 2013 Sep 27.
9
Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).胃黏膜癌前病变和病灶的处理(MAPS):欧洲胃肠道内镜学会(ESGE)、欧洲幽门螺杆菌研究组(EHSG)、欧洲病理学会(ESP)和葡萄牙消化内镜学会(SPED)指南
Endoscopy. 2012 Jan;44(1):74-94. doi: 10.1055/s-0031-1291491. Epub 2011 Dec 23.
10
Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).胃黏膜癌前状态和病变的管理(MAPS):欧洲胃肠道内镜学会(ESGE)、欧洲幽门螺杆菌研究组(EHSG)、欧洲病理学会(ESP)和葡萄牙消化内镜学会(SPED)的指南。
Virchows Arch. 2012 Jan;460(1):19-46. doi: 10.1007/s00428-011-1177-8. Epub 2011 Dec 22.
Helicobacter. 1996 Sep;1(3):138-44. doi: 10.1111/j.1523-5378.1996.tb00027.x.
4
Epidemiology of Helicobacter pylori infection among 4742 randomly selected subjects from Northern Ireland.对北爱尔兰随机选取的4742名受试者进行幽门螺杆菌感染的流行病学研究。
Int J Epidemiol. 1997 Aug;26(4):880-7. doi: 10.1093/ije/26.4.880.
5
Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking.消化性溃疡危险因素的Meta分析。非甾体抗炎药、幽门螺杆菌与吸烟。
J Clin Gastroenterol. 1997 Jan;24(1):2-17. doi: 10.1097/00004836-199701000-00002.
6
Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials.幽门螺杆菌筛查预防胃癌的成本效益建模:临床试验的一项任务
Lancet. 1996 Jul 20;348(9021):150-4. doi: 10.1016/s0140-6736(96)01501-2.
7
Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group.17个群体中3194名无症状受试者的幽门螺杆菌感染流行病学及危险因素。欧洲胃癌研究组
Gut. 1993 Dec;34(12):1672-6. doi: 10.1136/gut.34.12.1672.
8
Seroconversion for Helicobacter pylori.幽门螺杆菌血清转化
Lancet. 1993 Aug 7;342(8867):328-31. doi: 10.1016/0140-6736(93)91473-y.
9
H pylori and gastric cancer.
Lancet. 1994 Jan 22;343(8891):243-4.
10
Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. Helicobacter pylori Serology Study Group.八种市售幽门螺杆菌血清学检测试剂盒的多实验室比较。幽门螺杆菌血清学研究组。
Eur J Clin Microbiol Infect Dis. 1995 May;14(5):428-33. doi: 10.1007/BF02114899.